Best Abstracts: Valve & Structural Heart | Mitral Valve and Other Valve & Structural Heart Topics

Moderator(s)

• 

  Yashasvi Chugh, MD

  Structural and Interventional Cardiologist
  Baylor Heart & Vascular Hospital, Dallas, Texas, Texas, United States

  No relationships to disclose
• 

  Santiago Garcia, MD

  Director, Structural Heart Program and Harold C. Schott Foundation Endowed Chair for Structural and Valvular Heart Disease
  The Christ Hospital
  Cincinnati, Ohio, United States

  Disclosure(s): BSCI: Advisory Committee/Board Member (Ongoing); Edwards Lifesciences: Advisory Committee/Board Member (Ongoing), Consulting fees or other remuneration (Ongoing); Medtronic Cardiovascular: Consultant (Ongoing)

Presentations:

• 2:00 PM – 2:10 PM ET

  Impact of Mitral Annular Calcification on Outcomes After Mitral Transcatheter Edge-to-Edge Repair
  

  Speaker: Taha Hatab, MD – Houston Methodist Hospital
• 2:10 PM – 2:15 PM ET

  Panel Discussion
• 2:15 PM – 2:25 PM ET

  Short- and Medium-Term Mortality in ESRD Patients Undergoing Mitraclip Therapy - A Multicenter Retrospective Cohort Study
  

  Speaker: Mahima Kaur Zandu, MD (she/her/hers) – University of Arizona College of Medicine, Tucson
• 2:25 PM – 2:30 PM ET

  Panel Discussion
• 2:30 PM – 2:40 PM ET

  IMPELLA Utilization in High-Risk Percutaneous Coronary Intervention Mitigates the Risks of Procedural and Clinical Adverse Events Independent of Left Ventricular Ejection Fraction: The Protect III Study
  

  Speaker: Arsalan Abu-Much, MD – The Cardiovascular Research Foundation-New York
• 2:40 PM – 2:45 PM ET

  Panel Discussion
• 2:45 PM – 2:55 PM ET

  Incremental Predictive Value of Cardiac Troponin Positivity and Right Ventricular Strain Added to PESI Risk Class in Submassive Pulmonary Embolism
  

  Speaker: Ufuk Vardar, MD (he/him/his) – John H. Stroger Hospital of Cook County
• 2:55 PM – 3:00 PM ET

  Panel Discussion
• 3:00 PM ET

  Adjourn